Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00187525

A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration

Frontotemporal Lobar Degeneration Clinical Trial

Clinical Trial Summary

This is a 52-week, multicenter, open label trial of memantine (Namenda) for frontotemporal lobar degeneration (FTLD). The goal is to determine the safety and tolerability of this FDA-approved medication for Alzheimer's Disease in patients with FTLD. Secondary outcome measures include cognitive batteries, rating scales for activities of daily living and neuropsychiatric symptoms. All patients receive the FDA-approved dose of this medication for Alzheimer's disease.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

  • Frontotemporal Lobar Degeneration
Clinical Trial Details
NCT number NCT00187525
Study type Interventional
Source University of California, San Francisco
Contact
Status Completed
Phase Phase 4
Start date May 2004
Completion date October 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT01925196 - Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation
Active, not recruiting NCT04516499 - Neurofilament Surveillance Project (NSP)
Recruiting NCT05456503 - PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using PI-2620 Phase 3
Recruiting NCT03030586 - ADDIA Proof-of-Performance Clinical Study
Completed NCT02590276 - Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS) N/A
Completed NCT00677885 - P-glycoprotein Function in Brain Diseases
Completed NCT02333942 - Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
Recruiting NCT05741853 - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia N/A
Completed NCT02213458 - Care Ecosystem: Navigating Patients and Families Through Stages of Care N/A
Completed NCT04287738 - Care Ecosystem: Navigating Patients and Families Through Stages of Care, Extension Trial N/A
Active, not recruiting NCT04937452 - Dopaminergic Therapy for Frontotemporal Dementia Patients Phase 2
Completed NCT03606798 - Multidisciplinary and Personalized Care of Behavioral Disorders in Frontotemporal Lobar Degeneration. N/A
Recruiting NCT01962064 - Social Cognition in Ageing and in Frontotemporal Lobar Degeneration N/A
Recruiting NCT05956834 - A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
Completed NCT00088751 - Treatment Study of Frontotemporal Dementia N/A
Enrolling by invitation NCT04635540 - Decreased Empathy and Emotion Recognition in Patients With Neurodegenerative Disease N/A
Completed NCT00604591 - Effects of Tolcapone on Frontotemporal Dementia Phase 2
Completed NCT03508024 - Patients With Alzheimer's Disease or Related Youth Disease
Completed NCT00613119 - PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
Recruiting NCT02964611 - Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration